6-K ·Filed Jul 22, 2026

ICLR

ICON PLC
NEUTRAL
Impact 4/10
Horizondays Processed2mo ago SEC0001628280-26-049100
Notable filing: 6-K
Actionable Insight • Neutral

This filing itself is non-eventful, but the upcoming Q2 earnings release on July 29 is a critical catalyst given the prior restatement and control weaknesses. Traders should position for elevated volatility around the earnings call, with particular focus on revenue quality, backlog trends, and any updates on remediation of material weaknesses.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
ICLR ▲ +3.11% at T+20d
NEUTRAL call ✓ call won +3.11% · α vs SPY +0.22% · entry $167.28 → $172.49
Next anchor: T+60d in 13d
Latest observation: T+49 -31.00% FF3 residual α
Entry anchored
Jul 22, 04:01 AM ET
via exchange tick
T+1d
+1.82%
call +1.82% · α +3.05%
$170.32
settled 2mo ago
T+5d
+6.52%
call +6.52% · α +8.92%
$178.18
settled 2mo ago
T+20d
+3.11%
call +3.11% · α +0.22%
$172.49
settled 6w ago
T+60d
—
call — · α —
—
in 13d

Price Chart

Loading chart...

Executive Summary

ICON plc filed a 6-K on July 22, 2026, solely to announce the scheduling of its Q2 2026 earnings release for July 29, 2026, and a conference call for July 30, 2026. This is a routine administrative filing with no financial results or material business updates. The filing's significance is elevated by the cross-filing context of the May 27, 2026 20-F, which disclosed a $92.7M revenue restatement for FY2024, material weaknesses in internal controls, and a $364.2M goodwill impairment, making this upcoming earnings call a high-stakes event for investors seeking clarity on the company's financial health and remediation progress.

Key Facts

  • ICON will release Q2 2026 financial results after market close on July 29, 2026.
  • A conference call to discuss results is scheduled for July 30, 2026 at 8:00 AM ET.
  • The filing is a routine earnings schedule announcement with no financial data or guidance.
  • Cross-filing context: the prior 20-F (May 27, 2026) disclosed a $92.7M FY2024 revenue overstatement, material weaknesses, and a $364.2M goodwill impairment, making this earnings release a key credibility test.

Financial Impact

No financial figures reported in this filing. The upcoming earnings release will be closely watched following the prior restatement of $92.7M in FY2024 revenue and a $364.2M goodwill impairment.

revenuenetIncomeguidance

Risk Factors

  • The prior restatement and material weaknesses create significant downside risk if Q2 results show further revenue recognition issues or guidance is withdrawn.
  • Nasdaq deficiency notice from delayed 20-F filing adds delisting overhang that could be triggered by further filing delays.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Commercial Physical & Biological Research
Analyst Consensus
67% bullish (24 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001628280-26-049100
Document: pressrelease-iconplcschedu.htm0001628280-26-049100
Document: 0001628280-26-049100-index-headers.html0001628280-26-049100
Document: 0001628280-26-049100-index.html0001628280-26-049100
Document: 0001628280-26-049100.txt0001628280-26-049100
12 reports for ICLR
Performance horizon
67% Hit rate 4 of 6 directional calls best @ T+5▲ +3.92%Aug 6, 2026
Filters
Rows
Reports for ICLR — sortable, filterable
TypeNow
Aug 20, 2026
6w ago
6-K
NEUTRAL ★ 2/10
$174.27 $169.68▼ −2.63%▼ −2.63%$162.05 (−7.01%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$167.48 $169.31▲ +1.09%▲ +2.84%$162.05 (−3.24%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$167.48 $169.31▲ +1.09%▲ +2.84%$162.05 (−3.24%)
Aug 6, 2026
8w ago
6-K
BULLISH ★ 6/10
$161.17 $163.58▲ +1.50%▲ +0.90%$162.05 (+0.55%)
Jul 30, 2026
9w ago
6-K
BEARISH ★ 7/10
$165.53 $169.72▼ −2.53%▲ +1.43%$162.05 (+2.10%)
Jul 22, 2026
10w ago
6-K
NEUTRAL ★ 4/10
$167.28 $172.49▲ +3.11%▲ +0.22%$162.05 (−3.13%)
Jun 23, 2026
14w ago
6-K
BEARISH ★ 6/10
$158.17 $167.28▼ −5.76%▼ −3.83%$162.05 (−2.45%)
Jun 23, 2026
14w ago
6-K
NEUTRAL ★ 5/10
$158.17 $167.28▲ +5.76%▲ +3.83%$162.05 (+2.45%)
Jun 17, 2026
15w ago
6-K
NEUTRAL ★ 2/10
$146.00 $170.00▲ +16.44%▲ +15.91%$162.05 (+10.99%)
May 27, 2026
18w ago
6-K
BEARISH ★ 8/10
$136.80 $169.86▼ −24.17%▼ −27.31%$162.05 (−18.46%)
Showing 10 of 12

US Market Status

Market Closed — Opens Mon (38h 10m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access